Peptide Based Hematological Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Aug-2017
  • Tables : 140
  • Figures : 42
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT189MR
  • Format : ppt

Due to the advances in technology, the manufacturers and suppliers are encouraged to seek novel methods for peptide manufacturing, which is bound to improve the production of longer and complex chain of peptides and reduce the cost of production. Moreover, due to the automation of instruments, with improvements in the purification process and reduction in the total waste generated, are the driving factors triggering the growth of the global peptide therapeutics market. However, the synthesis and purification of long peptides is challenging for the manufacturers. Also, the rise in modifications and the addition of more unnatural amino acids have further increased the complications in peptide synthesis. This makes the manufactures of peptides difficult, and therefore the gap between demand and supply is increasing. Also, the manufacturing of peptides is a costly process, which hampers the growth of the global peptide therapeutics market.

Haematological disorders are the disorders related to problems in blood and blood components such as red blood cells, white blood cells, platelets, blood vessels, lymph nodes, spleen, bone marrow and the problems related to the proteins involved in bleeding and clotting (haemostasis and thrombosis). Therapeutic peptides are used in the treatment of haematological disorders mentioned above. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.  

This Fact.MR report on the global peptide based hematological disorders therapeutics market forecasts that the global peptide based hematological disorders therapeutics market will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

Market Taxonomy

Drug

Distribution Channel

Icatibant

Hospital Pharmacies

Ecallantide

Retail Pharmacies

 

Online Pharmacies

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue

The market in North America is set to dominate the global peptide based hematological disorders therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based hematological disorders therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.

Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022

As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.  

Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Peptide Based Hematological Disorders Therapeutics Market - Executive Summary

2. Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
       2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
       2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
       3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Ecallantide Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Distribution Channel 
4.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
       4.1.1. Hospital Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Retail Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Online Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       5.1.1. North America Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.2. Latin America Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.3. Europe Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.4. Japan Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.5. APEJ Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.6. MEA Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. North America Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       6.1.1. Revenue (US$ Mn) Comparison, By Drug 
       6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
6.2. Canada Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       6.2.1. Revenue (US$ Mn) Comparison, By Drug 
       6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Latin America Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
7.1. Brazil Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Drug 
       7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.2. Mexico Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Drug 
       7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.3. Argentina Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       7.3.1. Revenue (US$ Mn) Comparison, By Drug 
       7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Europe Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
8.1. Germany Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Drug 
       8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.2. UK Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Drug 
       8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.3. France Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Drug 
       8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.4. Spain Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       8.4.1. Revenue (US$ Mn) Comparison, By Drug 
       8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.5. Italy Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       8.5.1. Revenue (US$ Mn) Comparison, By Drug 
       8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.6. Nordic Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       8.6.1. Revenue (US$ Mn) Comparison, By Drug 
       8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. Japan Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
9.1. Japan  Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Drug 
       9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. APEJ Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
10.1. China Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Drug 
       10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.2. India Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       10.2.1. Revenue (US$ Mn) Comparison, By Drug 
       10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.3. Malaysia Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       10.3.1. Revenue (US$ Mn) Comparison, By Drug 
       10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.4. Thailand Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       10.4.1. Revenue (US$ Mn) Comparison, By Drug 
       10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.5. Singapore Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       10.5.1. Revenue (US$ Mn) Comparison, By Drug 
       10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.6. Australia Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       10.6.1. Revenue (US$ Mn) Comparison, By Drug 
       10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. MEA Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
11.1. GCC Countries Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Drug 
       11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.2. South Africa Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Drug 
       11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.3. Nigeria Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Drug 
       11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.4. Israel Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Drug 
       11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

12. Global Peptide Based Hematological Disorders Therapeutics Market Competition Landscape and Company Profile
12.1. Company Share Analysis By Region
12.2. Shire plc
       12.2.1. Company Overview
       12.2.2. Peptide Based Hematological Disorders Therapeutics Market Drug list
       12.2.3. Peptide Based Hematological Disorders Therapeutics Market Drug Sales Data and Key Financials
       12.2.4. Key Developments
       12.2.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

TABLE 1 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Icatibant Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Icatibant Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Icatibant Segment Market Share, By Region 2012-2016
TABLE 7 Global Icatibant Segment Market Share, By Region 2017-2022
TABLE 8 Global Icatibant Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Ecallantide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Ecallantide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Ecallantide Segment Market Share, By Region 2012-2016
TABLE 12 Global Ecallantide Segment Market Share, By Region 2017-2022
TABLE 13 Global Ecallantide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global Hospital Pharmacies Segment Market Share, By Region 2012-2016
TABLE 17 Global Hospital Pharmacies Segment Market Share, By Region 2017-2022
TABLE 18 Global Hospital Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Retail Pharmacies Segment Market Share, By Region 2012-2016
TABLE 22 Global Retail Pharmacies Segment Market Share, By Region 2017-2022
TABLE 23 Global Retail Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Online Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Online Pharmacies Segment Market Share, By Region 2012-2016
TABLE 27 Global Online Pharmacies Segment Market Share, By Region 2017-2022
TABLE 28 Global Online Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 29 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 30 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 31 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 32 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 33 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 34 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 35 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 36 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 37 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 38 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 39 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 40 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 41 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 42 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 43 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 44 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 45 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 46 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 47 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 48 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 49 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 50 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 51 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 52 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 53 US Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 54 US Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 55 US Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 56 US Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 57 Canada Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 58 Canada Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 59 Canada Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 60 Canada Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 61 Brazil Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 62 Brazil Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 63 Brazil Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 64 Brazil Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 65 Mexico Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 66 Mexico Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 67 Mexico Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 68 Mexico Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 69 Argentina Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 70 Argentina Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 71 Argentina Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 72 Argentina Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 73 Germany Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 74 Germany Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 75 Germany Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 76 Germany Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 77 UK Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 78 UK Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 79 UK Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 80 UK Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 81 France Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 82 France Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 83 France Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 84 France Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 85 Spain Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 86 Spain Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 87 Spain Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 88 Spain Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 89 Italy Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 90 Italy Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 91 Italy Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 92 Italy Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 93 Nordic Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 94 Nordic Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 95 Nordic Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 96 Nordic Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 97 Japan  Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 98 Japan  Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 99 Japan  Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 100 Japan  Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 101 China Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 102 China Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 103 China Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 104 China Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 105 India Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 106 India Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 107 India Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 108 India Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 109 Malaysia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 110 Malaysia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 111 Malaysia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 112 Malaysia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 113 Thailand Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 114 Thailand Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 115 Thailand Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 116 Thailand Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 117 Singapore Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 118 Singapore Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 119 Singapore Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 120 Singapore Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 121 Australia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 122 Australia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 123 Australia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 124 Australia Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 125 GCC Countries Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 126 GCC Countries Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 127 GCC Countries Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 128 GCC Countries Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 129 South Africa Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 130 South Africa Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 131 South Africa Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 132 South Africa Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 133 Nigeria Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 134 Nigeria Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 135 Nigeria Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 136 Nigeria Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 137 Israel Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 138 Israel Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 139 Israel Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 140 Israel Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022

FIG. 1 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Icatibant Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Icatibant Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Icatibant Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Ecallantide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Ecallantide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Ecallantide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 20 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 21 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 22 North America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 23 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 24 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 25 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 26 Latin America Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 27 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 28 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 29 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 30 Europe Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 31 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 32 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 33 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 34 Japan Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 35 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 36 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 37 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 38 APEJ Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 39 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 40 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 41 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 42 MEA Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development